ワルデンシュトレームマクログロブリン血症（リンパ形質細胞性リンパ腫）：世界の臨床試験レビュー（2023年上半期）

当レポートは、ワルデンシュトレームマクログロブリン血症（リンパ形質細胞性リンパ腫）について調査しており、世界主要国において実施された臨床試験数とその平均登録数の概要、地域・フェーズ・臨床試験ステータス・エンドポイントステータス・スポンサータイプ別の臨床試験、臨床試験が進行中の薬剤、過去5年間の登録動向などのデータを掲載しています。

目次

目次

表のリスト

図のリスト

• レポートガイダンス
• 臨床試験調査範囲
• 地域別の臨床試験
• 国別の臨床試験と平均登録
• アジア太平洋において臨床試験に貢献している主要5か国
• 欧州において臨床試験に貢献している主要5か国
• 北米において臨床試験に貢献している主要国
• 中東とアフリカにおいて臨床試験に貢献している主要国
• 中南米において臨床試験に貢献している主要5か国
• G7諸国別：腫瘍臨床試験におけるワルデンシュトレームマクログロブリン血症（リンパ形質細胞性リンパ腫）の割合
• フェーズ別：G7諸国における臨床試験
• 臨床試験ステータス別：G7諸国における臨床試験
• E7諸国別：腫瘍臨床試験におけるワルデンシュトレームマクログロブリン血症（リンパ形質細胞性リンパ腫）の割合
• フェーズ別：E7諸国における臨床試験
• 臨床試験ステータス別：E7諸国における臨床試験
• フェーズ別の臨床試験
• フェーズ別の進行中の臨床試験
• 臨床試験ステータス別の臨床試験
• エンドポイントステータス別の臨床試験
• 一定期間にわたって募集された被験者
• スポンサータイプ別の臨床試験
• 主要スポンサー
• 治療薬の臨床試験に参加している主要企業
• 主要薬剤
• 臨床試験プロファイルのスナップショット

付録

• 略語
• 定義
• 調査手法
• 2次調査
• GlobalDataについて
• お問い合わせ
• 免責事項
• 情報源

List of Tables

List of Tables

• Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Therapeutics, Global, Clinical Trials by Region, 2023*
• Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top

List of Figures

List of Figures

• Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Therapeutics, Global, Clinical Trials by Region (%), 2023*
• Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Therapeutics, Global, Clinical Trials and Average Enrollment b

Abstract

GlobalData's clinical trial report, "Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update" provides an overview of Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Clinical trials scenario. This report provides top line data relating to the clinical trials on Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• The report provides a snapshot of the global clinical trials landscape
• Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
• The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
• The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
• The Report provides enrollment trends for the past five years
• Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

• Assists in formulating key business strategies with regards to investment
• Helps in identifying prominent locations for conducting clinical trials which saves time and cost
• Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
• Supports understanding of trials count and enrollment trends by country in global therapeutics market
• Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
• Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

List of Tables

List of Figures

• Report Guidance
• GlobalData Clinical Trials Report Coverage
• Clinical Trials by Region
• Clinical Trials and Average Enrollment by Country
• Top Five Countries Contributing to Clinical Trials in Asia-Pacific
• Top Five Countries Contributing to Clinical Trials in Europe
• Top Countries Contributing to Clinical Trials in North America
• Top Five Countries Contributing to Clinical Trials in Middle East and Africa
• Top Five Countries Contributing to Clinical Trials in Central and South America
• Clinical Trials by G7 Countries: Proportion of Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) to Oncology Clinical Trials
• Clinical Trials by Phase in G7 Countries
• Clinical Trials in G7 Countries by Trial Status
• Clinical Trials by E7 Countries: Proportion of Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) to Oncology Clinical Trials
• Clinical Trials by Phase in E7 Countries
• Clinical Trials in E7 Countries by Trial Status
• Clinical Trials by Phase
• In Progress Trials by Phase
• Clinical Trials by Trial Status
• Clinical Trials by End Point Status
• Subjects Recruited Over a Period of Time
• Clinical Trials by Sponsor Type
• Prominent Sponsors
• Top Companies Participating in Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Therapeutics Clinical Trials
• Prominent Drugs
• Clinical Trial Profile Snapshots

Appendix

• Abbreviations
• Definitions
• Research Methodology
• Secondary Research
• About GlobalData
• Contact Us
• Disclaimer
• Source